Antibodies and antibody-drug conjugates in the treatment of Hodgkin lymphoma-Reference-Cited by-同舟云学术

Antibodies and antibody-drug conjugates in the treatment of Hodgkin lymphoma

Published:2014-05-09 Issue:1 Volume:93 Page:1-8
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Eichenauer Dennis A.¹²,Engert Andreas¹²

Affiliation:

1. First Department of Internal Medicine; University Hospital Cologne; Cologne Germany

2. German Hodgkin Study Group (GHSG); Cologne Germany

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12347/fullpdf

Reference54 articles.

1. Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Eichenauer;Ann Oncol,2011

2. Biology, clinical course and management of nodular lymphocyte-predominant hodgkin lymphoma;Nogova;Hematology Am Soc Hematol Educ Program,2006

3. Lymphocyte-predominant and classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin Study Group;Nogova;J Clin Oncol,2008

4. State of the art in the treatment of Hodgkin lymphoma;Borchmann;Nat Rev Clin Oncol,2012

5. Outcome and risk factors of patients with Hodgkin Lymphoma who relapse or progress after autologous stem cell transplant;Tresckow;Leuk Lymphoma,2014

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century;Blood Cancer Journal;2020-05

2. Hodgkin-Lymphome;Pathologie;2018-10-30

3. Antibody-Based Therapeutics in Oncology;Methods and Principles in Medicinal Chemistry;2017-08-14

4. Alternative salvage regimens for relapsed/refractory classical Hodgkin's lymphoma;Hematology;2016-03

5. Advances in the diagnosis and control of lymphomas;Salud Pública de México;2016-03